Cangrelor Interactions
There are 150 drugs known to interact with cangrelor, along with 1 disease interaction. Of the total drug interactions, 64 are major, 80 are moderate, and 6 are minor.
- View cangrelor disease interactions (1)
Medications known to interact with cangrelor
Note: Showing generic names only.
- abciximab
- abrocitinib
- acalabrutinib
- ado-trastuzumab emtansine
- aducanumab
- alemtuzumab
- alteplase
- anacaulase topical
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- avapritinib
- cabozantinib
- calaspargase pegol
- caplacizumab
- capsicum
- celecoxib
- chamomile
- cilostazol
- citalopram
- clomipramine
- clopidogrel
- clove
- collagenase clostridium histolyticum
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dipyridamole
- donanemab
- dong quai
- drotrecogin alfa
- duloxetine
- fenfluramine
- fenoprofen
- fenugreek
- feverfew
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- panobinostat
- paroxetine
- pegaspargase
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- pirtobrutinib
- plasminogen, human
- ponatinib
- prasugrel
- tafasitamab
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
- turmeric
Cangrelor disease interactions
There is 1 disease interaction with cangrelor which include:
Report options
More about cangrelor
- cangrelor consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Plavix
Plavix (clopidogrel) is used to prevent blood clots after a recent heart attack or stroke. Includes ...
Integrilin
Integrilin prevents blood clots or heart attack in people with severe chest pain and in patients ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Angiomax
Angiomax is used for angina, percutaneous coronary intervention
ReoPro
ReoPro is used to lessen the chance of heart attack in people who need percutaneous coronary ...
Abciximab
Abciximab systemic is used for high risk percutaneous transluminal angioplasty
Eptifibatide
Eptifibatide systemic is used for acute coronary syndrome, angina, heart attack, percutaneous ...
Bivalirudin
Bivalirudin systemic is used for angina, percutaneous coronary intervention
Clopidogrel
Clopidogrel systemic is used for acute coronary syndrome, acute coronary syndrome, prophylaxis ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.